Avanos Medical, Inc. Announces Second Quarter 2018 Results, Raises Full-Year 2018 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 31c, Revenues Beat; Boosts FY18 EPS, Sales Growth Guidance
August 7, 2018 7:18 AM EDTAvanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.48, $0.31 better than the analyst estimate of $0.17. Revenue for the quarter came in at $160.9 million versus the consensus estimate of $157.14 million.
Second quarter net sales from continuing operations, or Medical Device sales, were $161 million, an 8 percent increase from the prior year. On a constant currency... More